TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CERS

Cerus Corporation

Healthcare · Medical Devices

2.70$ +5.1% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Cerus Corporation (CERS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 206 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CERS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
37 34 37 44 61 75 92 131 162 156 180 206
21 23 20 23 32 33 41 63 75 70 81 94
15 11 17 21 29 41 51 67 87 86 100 112
22 26 31 34 43 60 64 64 64 68 59 68
38 46 49 52 57 66 67 81 83 81 76 81
60 72 78 79 84 107 109 116 121 116 114 121
-44 -61 -61 -58 -55 -66 -58 -49 -34 -30 -14 -8.7
0.6 1.7 2.4 3.0 4.0 6.1 3.7 4.9 5.8 8.4 8.9 8.3
-38 -60 -63 -57 -57 -71 -60 -54 -42 -37 -21 -15
0.2 -3.7 0.2 3.9 0.2 0.3 0.3 0.3 0.5 0.3 0.2 0.4
-39 -56 -63 -61 -58 -71 -60 -54 -43 -37 -21 -16
-37 -56 -58 -52 -54 -64 -55 -46 -31 -26 -10 -5.5

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?